DRW Securities Portfolio holdings
DRW Securities is a majority-owned subsidiary of the proprietary trading firm DRW and engages in proprietary trading itself. DRW began in 1992 under Don Wilson, who had traded options at the Chicago Mercantile Exchange, and takes its name from his initials. The group builds its trading on modeling, technology and research, and is active on exchanges on five continents across a wide variety of products. Its other businesses include Cumberland DRW, launched in 2014 as a crypto trading counterparty for institutional investors, DRW Venture Capital, which invests in fintech companies, and Convexity Properties, a real estate investor started in 2008. DRW also bought the trading firm Chopper Trading in 2015.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
|
+$27.4M |
| 2 |
Gilead Sciences
GILD
|
+$5.66M |
| 3 |
State Street SPDR Portfolio Intermediate Term Treasury Index ETF
SPTI
|
+$3.97M |
| 4 |
Pfizer
PFE
|
+$3.04M |
| 5 |
Novo Nordisk
NVO
|
+$2.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$10.2M |
| 2 |
Vanguard Total Bond Market
BND
|
+$8.62M |
| 3 |
TVIX
VelocityShares Daily 2x VIX Short Term ETN
TVIX
|
+$5.39M |
| 4 |
bluebird bio
BLUE
|
+$3.78M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 96.17% |
| 2 | Financials | 1.46% |
| 3 | Healthcare | 1.33% |
| 4 | Industrials | 0.34% |
| 5 | Technology | 0.24% |
Similar funds
DRW Securities's Q3 2015 Portfolio in Review
As of Q3 2015, DRW Securities held 139 positions worth $903M, down 1.9% from $921M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
DRW Securities's Q3 2015 filing shows 30 new, 24 increased, 13 reduced and 62 closed positions. Its largest new stake was Gilead Sciences: 51,000 shares worth $5.01M. The largest sale was Vertex Pharmaceuticals, an estimated $10.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 94% a quarter earlier, followed by Financials and Healthcare.
- DRW Securities's largest Q3 2015 buy was Gilead Sciences: 51,000 shares worth $5.01M.
- DRW Securities added most to VelocityShares Daily Inverse VIX Short Term ETN in Q3 2015, an estimated $27.4M increase.
- DRW Securities's biggest Q3 2015 reduction was Vanguard Total Bond Market, cutting an estimated $8.62M.
- DRW Securities fully exited Vertex Pharmaceuticals in Q3 2015, selling an estimated $10.2M.
- DRW Securities's ten largest holdings make up 93% of its $903M portfolio in Q3 2015.
- DRW Securities opened 30 new positions and closed 62 in Q3 2015.
- DRW Securities's portfolio value fell 1.9% quarter-over-quarter to $903M.
Based on DRW Securities's 13F filing for Q3 2015, filed 16 Nov 2015.